potassium phosphates

Generic: potassium phosphates

Labeler: american regent, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name potassium phosphates
Generic Name potassium phosphates
Labeler american regent, inc.
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

potassium phosphate, dibasic 236 mg/mL, potassium phosphate, monobasic 224 mg/mL

Manufacturer
American Regent, Inc.

Identifiers & Regulatory

Product NDC 0517-2051
Product ID 0517-2051_e76a57d0-94d0-4eed-9969-66f2c553ed5c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA216274
Listing Expiration 2026-12-31
Marketing Start 2023-10-13

Pharmacologic Class

Classes
increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] osmotic activity [moa] osmotic laxative [epc] potassium compounds [cs] potassium salt [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 05172051
Hyphenated Format 0517-2051

Supplemental Identifiers

RxCUI
1928567 1928569 2667657
UNII
4J9FJ0HL51 CI71S98N1Z

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name potassium phosphates (source: ndc)
Generic Name potassium phosphates (source: ndc)
Application Number ANDA216274 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 236 mg/mL
  • 224 mg/mL
source: ndc
Packaging
  • 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-2051-25) / 5 mL in 1 VIAL, SINGLE-DOSE (0517-2051-01)
source: ndc

Packages (1)

0517-2051-25 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-2051-25) / 5 mL in 1 VIAL, SINGLE-DOSE (0517-2051-01)

Ingredients (2)

potassium phosphate, dibasic (236 mg/mL) potassium phosphate, monobasic (224 mg/mL)

Linked Drug Pages (1)

Potassium Phosphates ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "e76a57d0-94d0-4eed-9969-66f2c553ed5c", "openfda": {"unii": ["4J9FJ0HL51", "CI71S98N1Z"], "rxcui": ["1928567", "1928569", "2667657"], "spl_set_id": ["41a85cca-c463-4f39-9335-177b04c290a9"], "manufacturer_name": ["American Regent, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 TRAY (0517-2051-25)  / 5 mL in 1 VIAL, SINGLE-DOSE (0517-2051-01)", "package_ndc": "0517-2051-25", "marketing_start_date": "20231013"}], "brand_name": "Potassium Phosphates", "product_id": "0517-2051_e76a57d0-94d0-4eed-9969-66f2c553ed5c", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Potassium Compounds [CS]", "Potassium Compounds [CS]", "Potassium Salt [EPC]", "Potassium Salt [EPC]"], "product_ndc": "0517-2051", "generic_name": "potassium phosphates", "labeler_name": "American Regent, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Potassium Phosphates", "active_ingredients": [{"name": "POTASSIUM PHOSPHATE, DIBASIC", "strength": "236 mg/mL"}, {"name": "POTASSIUM PHOSPHATE, MONOBASIC", "strength": "224 mg/mL"}], "application_number": "ANDA216274", "marketing_category": "ANDA", "marketing_start_date": "20231013", "listing_expiration_date": "20261231"}